15-03-2023, 04:41

Kura Oncology Announces Acceptance of Two Abstracts for

– Presentations to highlight preclinical data supporting combination of FTIs with KRASG12C inhibitors and tyrosine
Globe Newswire15-03-2023, 04:41
16-02-2023, 19:46

Kura Oncology to Report Fourth Quarter and Full Year 2022

SAN DIEGO, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical
Globe Newswire16-02-2023, 19:46